Harvard Bioscience, Inc. (HBIO) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Harvard Bioscience, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.118 Good day, and welcome to the second quarter 2025 Harvard Bioscience Earnings Conference 00:00:05.118 -- 00:00:08.943 Call. All participants will be in listen-only mode. 00:00:08.943 -- 00:00:13.049 After today's presentation, there will be an opportunity to ask questions. 00:00:13.049 -- 00:00:17.455 To ask a question, please press star 1-1 on your touchtone telephone. 00:00:17.455 -- 00:00:21.681 Please note this event is being recorded. I'm now going to turn the conference over to 00:00:21.681 -- 00:00:25.607 Taylor Krafchick, Senior Vice President at Ellipsis TA. 00:00:25.607 -- 00:00:26.288 Please go ahead. 00:00:26.288 -- 00:00:27.870 Thank 00:00:27.870 -- 00:00:29.832 you, operator, and good morning, everyone. 00:00:29.832 -- 00:00:33.497 Thank you for joining the Harvard Bioscience Second Quarter 2025 Earnings Conference 00:00:33.497 -- 00:00:38.043 Call. Leading the call today will be John Duke, President and Chief Executive Officer, 00:00:38.043 -- 00:00:41.087 and Mark Frost, Interim Chief Financial Officer. 00:00:41.087 -- 00:00:44.913 In conjunction with today's recorded call, we have provided a presentation that will 00:00:44.913 -- 00:00:47.997 be referenced during our remarks that is posted to the Investor Relations section of 00:00:47.997 -- 00:00:50.878 our website at investors.harvardbioscience.com. 00:00:52.603 -- 00:00:57.190 Please note that statements made today in discussion that are not historical facts, including 00:00:57.190 -- 00:01:01.576 statements on management's expectations of future events or future financial performance 00:01:01.576 -- 00:01:05.583 are forward-looking statements and are made pursuant to the safe harbor provisions of 00:01:05.583 -- 00:01:09.069 the Private Securities Litigation Ref...